$304 Million is the total value of Ghost Tree Capital, LLC's 70 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $7,959,400 | -10.8% | 85,000 | -15.0% | 2.62% | -11.1% |
| PCVX | Sell | VAXCYTE INC | $7,137,200 | -49.0% | 140,000 | -50.0% | 2.35% | -49.2% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $5,816,700 | -65.4% | 115,000 | -68.1% | 1.91% | -65.5% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $4,848,800 | -50.2% | 40,000 | -52.9% | 1.60% | -50.4% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $4,014,500 | -69.8% | 350,000 | -33.3% | 1.32% | -69.9% |
| Sell | AMYLYX PHARMACEUTICALS INC | $3,936,650 | -66.8% | 215,000 | -60.9% | 1.30% | -66.9% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $3,380,166 | -52.5% | 98,951 | -46.5% | 1.11% | -52.7% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $2,904,000 | -60.4% | 200,000 | -42.9% | 0.96% | -60.5% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $2,613,600 | -63.8% | 60,000 | -70.0% | 0.86% | -63.9% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $2,490,750 | -76.4% | 225,000 | -65.4% | 0.82% | -76.5% |
| Sell | ASTRIA THERAPEUTICS INC | $2,238,000 | -10.5% | 300,000 | -0.1% | 0.74% | -10.8% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $2,128,000 | -15.3% | 175,000 | -12.5% | 0.70% | -15.6% |
| BMEA | Sell | BIOMEA FUSION INC | $894,400 | -78.6% | 65,000 | -65.8% | 0.29% | -78.6% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $733,500 | -68.5% | 45,000 | -59.1% | 0.24% | -68.6% |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $632,546 | -67.2% | 243,287 | -41.0% | 0.21% | -67.3% |
| FGEN | Exit | FIBROGEN INC | $0 | – | -36,500 | -100.0% | -0.03% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -31,000 | -100.0% | -0.07% | – |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -10,865 | -100.0% | -0.08% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -16,675 | -100.0% | -0.22% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.23% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -27,578 | -100.0% | -0.24% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INCcall | $0 | – | -130,000 | -100.0% | -0.29% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -20,000 | -100.0% | -0.38% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.46% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.49% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -150,000 | -100.0% | -1.22% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -22,500 | -100.0% | -1.32% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -65,000 | -100.0% | -1.34% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -85,000 | -100.0% | -2.86% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -180,000 | -100.0% | -5.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.